Takuya Watanabe

Genetics · 2009

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Genetics — 10 citations into it; #4,933 of 6,854 by trust here, #3,081 by citations
• Cancer Research — 7 citations into it

Whom Takuya Watanabe trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. H. Ohgaki
2. P. Kleihues

Who trusts Takuya Watanabe overall

1. S. Nobusawa
2. H. Ohgaki
3. P. Kleihues
4. McKinsey L. Goodenberger

Papers from Takuya Watanabe's perspective

Ordered by how strongly the researchers Takuya Watanabe trusts endorse each paper. Same corpus, a different order for every researcher.

1. An Integrated Genomic Analysis of Human Glioblastoma Multiforme (Science)
2. IDH1 and IDH2 mutations in gliomas. (New England Journal of Medicine)
3. Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α (Science)
4. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. (American Journal of Pathology)
5. Analysis of the IDH1 codon 132 mutation in brain tumors (Acta Neuropathologica)
6. Prediction of central nervous system embryonal tumour outcome based on gene expression (Nature)
7. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. (Cancer Cell)
8. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. (Cancer Cell)
9. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. (The Lancet)
10. Pathology and genetics of tumours of the nervous system.

Their papers

• IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas (2009) — 712 citations
• IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. (2009) — 1,019 citations